Migraine Treatment Market is expected to grow with a 4% CAGR during 2023 to 2033

The global Migraine Treatment Market is predicted to generate a market value of US$ 3.2 billion in 2023 and a market value of US$ 4.74 billion by 2033, with a CAGR of 4% from 2023 to 2033. In the historical period 2018 to 2022, the Migraine Therapy market grew at a CAGR of 3%.

The condition is characterized by severe headaches, often accompanied by symptoms such as nausea, vomiting, and sensitivity to light and sound, significantly impacting quality of life by interfering with work, social activities, and other daily routines. There have been several advances in migraine treatment in recent years, with new medications and non-pharmacological approaches becoming available. This is expected to drive growth in the migraine treatments market, as patients seek out more effective and better-tolerated treatments.

Request a Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16751

Not just this, Healthcare spending is increasing in many countries, which is expected to drive demand for migraine treatments. As individuals become more affluent and more willing to spend on healthcare, demand for treatments is likely to increase.

Key Takeaways from the Market Study

• From 2018 to 2022, the migraine treatments market grew at a CAGR of 3%.
• The global migraine treatments market is expected to grow with a 4% CAGR during 2023 to 2033.
• As of 2033, the migraine treatments Market is expected to reach US$ 4.74 Billion.
• According to the FMI analysis, hospitals account for the largest market share.
• North America is expected to possess 40% market share for the migraine treatments market.
• The East & South Asia market is predicted to increase significantly throughout the forecast period, with a share of 20% during the forecast period. 

“A series of international level collaborations involving healthcare stakeholders across various institutional settings are fueling further clinical trials and research studies dedicated to discovering migraine treatments.” says an FMI analyst

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-16751

Market Competition

Key players in the market include companies such as Lundbeck Seattle BioPharmaceutical, Eli Lilly and Company, Amgen, Novartis, Allergan, Teva Pharmaceuticals, Biohaven Pharmaceuticals, Biohaven Pharmaceuticals, Dr. Reddy’s Labs, AbbVie, Impel NeuroPharma, Zosano Pharma, Aeon Biopharma Inc., Ionis Pharmaceuticals, Inc., and Charleston Laboratories along with healthcare providers and technology companies among other global players.

• In November 2022, A team of researchers at University College London (UCL) developed a novel gene therapy that offers promise in treating neurological and psychiatric disorders. The therapy targets overactive brain cells that are responsible for causing several brain diseases, including epilepsy, by reducing their excitability. By using DNA sequences that control gene expression, the therapy drives the production of molecules that prevent these overactive cells from firing, thereby curbing epileptic seizures. Notably, the technique selectively alters only overactive cells while sparing normally functioning cells.

In preclinical studies, the new treatment demonstrated a higher efficacy than previous gene therapies or anti-seizure drugs tested in the same model. The team observed an approximately 80% reduction in spontaneous seizures in epileptic mice treated with the therapy. Furthermore, the researchers believe that this gene therapy has the potential to treat other disorders where some brain cells are overactive, such as Parkinson’s disease.

Buy Now@ https://www.futuremarketinsights.com/checkout/16751

Key Segments Profiled in the Migraine Treatment Industry Survey

Drug Class:

• Zavegepant
• Atogepant
• Zolmitriptan

Route of Administration:

• Oral
• Parenteral
• Nasal Sprays

Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Treatment:

• Abortive Medicine
• Preventive Medicine

About the Healthcare Division at Future Market Insights

The healthcare team at Future Market Insights offers expert analysis, time efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis on key trends including competitive landscape, profit margin, and research development efforts.

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs